Merck to spin off assets with $6.5B in sales; 4Q profit up

Merck to spin off assets with $6.5B in sales; 4Q profit up

Adjusted earnings came to $2.98 billion, or $1.16 per share, beating projections from Wall Street analysts by a penny. The maker of Januvia Type 2 diabetes pills reported revenue of $11.87 billion, up …